104 matches.
- Firm AnnouncementsEpstein Becker Green Recognized Among the 2026 Listing of “Best Law Firms” by Best Lawyers®6 minute read
- PublicationsFDA Vaccine Suspensions: Outliers or the New Normal3 minute read
- EventsThe Jefferies Healthcare Services Conference: The Art of Identifying Quality - Strategies Sellers Should Model and Buyers Should Seek2 minute read
Firm AnnouncementsEpstein Becker Green Attorneys Honored for Excellence in the Legal Profession by Best Lawyers 202612 minute read- Firm AnnouncementsEpstein Becker Green Earns Top Honors in Legal 500 2025 for Excellence in Client Service and Achievements Across Key Health Care, Employment, and Transactional Practices3 minute read
- BlogsA Final Rule Bites the Dust, Part II: FDA Gives up on Regulating LDTs as Medical Devices4 minute read
Firm AnnouncementsEpstein Becker Green Recognized by Chambers USA 2025 for Delivering Excellence on Behalf of Healthcare, Labor & Employment, and White Collar Litigation Clients5 minute read
Videos & Podcasts- PublicationsThe LDT Final Rule Bites the Dust: Examining the Repercussions of the Federal Court’s Vacatur and What the Future May Hold16 minute read
- Firm AnnouncementsEpstein Becker Green Attorneys Honored for Excellence in the Legal Profession by Best Lawyers 202514 minute read
- Firm AnnouncementsEpstein Becker Green Receives National Recognition and Top Rankings in the 2024 Edition of Legal 5003 minute read
-
Firm AnnouncementsEpstein Becker Green Honored for Exceptional Performance in Key Practice Areas by Chambers USA 20245 minute read
- PublicationsState Supreme Courts and Ballot Initiatives: Arizona, Florida Exemplify the Abortion Battle Playing Out in the States14 minute read
- PublicationsFDA and OHRP Issue Joint Draft Guidance on Content, Organization, and Presentation of Consent Forms for Research Participants9 minute read
- BlogsBioMarin Subpoena Potentially Signals Continued Investigations into Sponsored Testing Programs4 minute read
- BlogsIn Alabama, Pre-Embryos are “Extrauterine Children” Under the State’s Wrongful Death Statute11 minute read
- PublicationsSponsored Genetic Testing Programs: Compliance Considerations Following DOJ False Claims Act Settlement13 minute read
- BlogsSharing Scientific Information with HCPs on Unapproved Uses of Medical Products: Dos and Don’ts Under FDA’s New Draft Guidance14 minute read
- BlogsFDA Issues Final Guidance on Informed Consent for IRBs, Clinical Investigators, and Sponsors4 minute read
- PublicationsWhat’s on the Agenda? Laboratory Developed Tests Added to the Unified Regulatory Agenda Signals FDA Movement Toward New Regulatory Framework26 minute read
Videos & Podcasts
Firm AnnouncementsEpstein Becker Green Earns National Recognition and High Rankings in the 2023 Edition of Legal 5003 minute read- PublicationsFDA Issues Draft Recommendations for Implementing Decentralized Clinical Trials20 minute read
Firm AnnouncementsEpstein Becker Green Recognized for Focused Excellence Across Core Practice Areas in Chambers USA 20235 minute read-
Videos & Podcasts
- BlogsAnti-Abortion Advocacy Groups’ Challenge to FDA-Approved Abortion Pill May Have Far-Reaching Consequences7 minute read
- EventsFrom Roe to Dobbs: Reviewing Changes to Reproductive Health Care Operations and Forecasting What’s Next2 minute read
- BlogsFive States Put Abortion Questions on the Ballot; Health Care and Other Employers Should Stay Tuned10 minute read
- Firm AnnouncementsEpstein Becker Green’s Amy Dow Honored in Crain’s 2022 Notable Women in Law2 minute read
- Firm Announcements2022 Edition of The Legal 500 Recognizes Epstein Becker Green with High Rankings in Health Care and Workforce Management3 minute read
-
Firm AnnouncementsChambers USA 2022 Recognizes Epstein Becker Green's Focused Excellence in Core Practice Areas: Distinguished in Healthcare, Labor & Employment, and Litigation4 minute read
- EventsEU-US Webinar: Shaping the Future of Artificial Intelligence (AI) Within Life SciencesSeptember 30, 20212 minute read
Firm AnnouncementsEpstein Becker Green’s Focused Excellence Lauded by Chambers USA in 2021 Edition of Leading Law Firms and Attorneys3 minute read- EventsDriving Diversity in Law & Leadership: From Recruitment to Retention - The Role of Sponsorship & Mentorship2 minute read
- PublicationsLegal and Compliance Considerations When Bringing Cellular Therapies to Market1 minute read
- BlogsIn Response to COVID-19, FDA Extends Enforcement Discretion for HCT/Ps Requiring Pre-Market Review2 minute read
- BlogsFDA to Resume Domestic Inspections with New Safety Measures After Temporary Pause Due to COVID-19 Health and Safety Concerns2 minute read
- Firm AnnouncementsEpstein Becker Green’s Focused Excellence in Health Care and Workforce Management Recognized in 2020 Edition of Chambers USA3 minute read
- BlogsFDA Issues Update to Guidance for Clinical Trials During the COVID-19 Pandemic6 minute read
- BlogsFDA Issues Guidance for Ongoing Clinical Trials During COVID-19 Pandemic5 minute read
- Media CoverageLaw360's Hottest Firms and Stories Features Cannabis Transaction Article by Epstein Becker Green Attorneys2 minute read
- Publications8 Best Practices for Cannabis Transaction Due Diligence1 minute read
- Firm AnnouncementsEpstein Becker Green Recognized as Top-Tier Law Firm by The Legal 500 United States, Receives Additional High Rankings4 minute read
- Firm AnnouncementsLegal 500 United States Recognizes Epstein Becker Green as Top-Tier Recommended Law Firm, Awards Additional High Rankings4 minute read
- EventsTOBI 2018: FDA Guidelines for Regenerative Cellular Therapies, Including Autologous Procedures1 minute read
- Media CoverageAmy Dow Quoted in "Right to Try Pros and Cons"2 minute read
- Media CoverageAmy Dow Quoted in "Congress Gives Patients the 'Right to Try' Experimental Drugs, Bill Heads to White House"3 minute read
- BlogsMedicare Secondary Payer Compliance: Non-Group Health Plans (NGHPs) (Part IV)8 minute read
- Media CoverageAmy Dow Quoted in "Compassionate Use: A Look into Goldwater Institute v. HHSand 'Right to Try' Legislation"3 minute read
-
Videos & Podcasts
- EventsFDLI Advertising and Promotion Conference: Risk Information in Direct-to-Consumer Broadcast Advertisements for Prescription Drugs1 minute read
- Firm AnnouncementsEpstein Becker Green Receives Top Rankings in The Legal 500 United States for 20173 minute read
- BlogsChicago Releases Draft Rules on Pharmaceutical Representative Licensure4 minute read
- Events17th Annual Conference on Fraud and Abuse in the Sale and Marketing of Drugs, Devices, and Medical Technology: Regulatory and Legal Considerations When Using Social Media to Promote Drugs and Medical Devices1 minute read
- Firm AnnouncementsEpstein Becker Green Attorneys Named to Law360 Editorial Advisory Boards2 minute read
- Media CoverageAmy Dow Featured in "Law360Life Sciences Editorial Advisory Board"1 minute read
- BlogsFDA Adopts New Designation Process for Regenerative Advanced Therapies5 minute read
- BlogsFDA Says Yes to Pre-Approval Communications with Payors but Reaffirms its Approach to Restrictions on Off-Label Communications12 minute read
-
Videos & Podcasts
- BlogsChicago Imposes Burdensome New Licensure and Disclosure Obligations on Pharmaceutical Representatives4 minute read
- BlogsFDA Announces November Public Hearing on Off-Label Communications: An Important Step Forward or a Signal that FDA is Headed Back to the Drawing Board?5 minute read
- Firm AnnouncementsEpstein Becker Green Receives Top Rankings in The Legal 500 United States for 20163 minute read
- BlogsFDA Issues Draft Guidance Encouraging More Widespread Use of Electronic Health Record Data in Clinical Trials5 minute read
- Media CoverageAmy Dow Quoted in "FDA Seeks Comments on Draft 3-D Device Printing Guidance"2 minute read
- Firm AnnouncementsEpstein Becker Green's Amy Dow Named to Law360 Life Sciences Editorial Advisory Board1 minute read
- Media CoverageAmy Dow Quoted in “How 2015 Became the Year of Prescription Drug Price Outrage”3 minute read
- EventsAHLA Advanced Compliance Education Series Part I: Advanced Issues in Pharmaceutical Manufacturer Compliance Programs1 minute read
- Firm AnnouncementsEpstein Becker Green Continues Chicago Expansion with Move to New Location1 minute read
- PublicationsThe Future of Research Using Electronic Medical Records Data2 minute read
- BlogsThe Future of Research Using Electronic Medical Records Data: Precision Medicine Initiative Privacy and Trust Guiding Principles Provide Another Piece of the Puzzle5 minute read
- Firm AnnouncementsEpstein Becker Green Receives Top Rankings in The Legal 500 United States for 20153 minute read
- Media CoverageAmy Dow Quoted in "US FDA Shows Willingness to Be Flexible in Using Foreign Device Clinical Trial Data"2 minute read
- Media CoverageAmy Dow Quoted in "Individuals Compassionate Use: Concerns for Drug Manufacturers Considering Participation"2 minute read
- Firm AnnouncementsEpstein Becker Green Attorneys Named to 2015 Law360 Editorial Advisory Boards2 minute read
- BlogsWill Promoted Video Pave the Way for Drug and Medical Device Promotion on Twitter?4 minute read
- PublicationsNIH Issues Proposed Rule Expanding Clinical Trial Registration and Reporting Obligations42 minute read
- BlogsFDA Launches Drug Trials Snapshot to Provide the Public with Information about the Clinical Trials Supporting New Drug Approvals2 minute read
- Media CoverageAmy Dow Elected Shareholder at Epstein Becker Green - Media Coverage Roundup1 minute read
- PublicationsFDA Continues to Exercise Its Authority to Speed Access to Products That May Aid in the Prevention and Treatment of Ebola Infection1 minute read
- BlogsFDA Continues to Exercise Its Authority to Speed Access to Products That May Aid in the Prevention and Treatment of Ebola Infection3 minute read
- Media CoverageEpstein Becker Green Mentioned in "Epstein Becker Elects Three Shareholders—All Are Women" - Bloomberg1 minute read
- Firm AnnouncementsEpstein Becker Green Demonstrates Its Commitment to Diversity Through Recent Shareholder Elections3 minute read
- PublicationsFDA Releases Draft Guidance Updating Agency Policies on the Informed Consent Process for Clinical Trials13 minute read
- EventsSocial Media Compliance Strategies and Benchmarking Summit: What's Next? What Can We Expect in 2014 and Beyond?1 minute read
- PublicationsWhat You Need to Know to Keep Your Company's Promotions Out of the Enforcement Spotlight2 minute read
- PublicationsMore of the Same: Recently Released FDA Social Media Guidance for the Life Sciences Industry13 minute read
- PublicationsSupreme Court Declines to Opine on Circuit Split Over Rule 9(b) Pleading Requirements for FCA Claims12 minute read
- PublicationsFDA Seeks Public Comment on Revised Draft Guidance for Industry: Distributing Scientific and Medical Publications on Unapproved New Uses—Recommended Practices16 minute read
- EventsACI's 2nd Practical and Tactical Art of the Deal in Medical Device Agreements: Bridging Points of Contention to Help Academics and Industry Create More Effective Agreements1 minute read
- PublicationsHEALTH REFORM: CMS Issues Final Regulations on Federal "Sunshine" Law for Manufacturers and GPOs26 minute read
- EventsPharmaceutical Compliance Congress (PCC) 20131 minute read
- EventsMed Tech Webcast Series: The Intersection of Product Liability and Regulatory Considerations: Effectively Managing Risks in Medical Device Labeling & Promotion3 minute read
- Firm AnnouncementsEpstein Becker Green Promotes 13 Attorneys in Four Practices - Health Care and Life Sciences, Labor and Employment, Litigation, and Corporate Services3 minute read
- Media CoverageAmy Dow Quoted in Article "Court: FDA Regulation of Stem Cell Therapy Not Barred by Practice of Medicine Defense"2 minute read
- EventsFDA Boot Camp: Understanding the Clinical Trial Process for Drugs and Biologics2 minute read
- PublicationsThe Department of Health and Human Services Requests Comments on Proposed Changes to the "Common Rule"13 minute read
- PublicationsMaine Repeals Pharmaceutical Disclosure Requirements Related to Marketing Costs, Drug Pricing, and Clinical Trials6 minute read
- PublicationsChapter 10, "Payment to Research Subjects," in Institutional Review Boards: A Primer, Second Edition1 minute read
- PublicationsClinical Research Regulatory Update: FDA Proposes Updates To Informed Consent Regulations, Issues Guidance On IRB Continuing Review12 minute read
- PublicationsTry It Before You Buy It: Maximizing Buyer Opportunities in Healthcare Regulatory Due Diligence Reviews of Life Sciences Companies, as appeared in Journal of Health & Life Sciences Law2 minute read
- PublicationsVermont Bans Gifts and Expands Disclosure Requirements for Payments to Health Care Providers10 minute read
- PublicationsFDA & OHRP Guidance on Data Retention and Other Considerations Applicable to Subjects Who Withdraw From Clinical Research17 minute read
- PublicationsFDA Issues Draft Guidance for Industry: Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses16 minute read
- EventsMaster Class on Managing Legal Risks in Structuring & Conducting International Clinical Trials1 minute read